Lyophilisation of influenza, rabies and Marburg lentiviral pseudotype viruses for the development and distribution of a neutralisation -assay-based diagnostic kit

Journal of Virological Methods

Volumn 210, Issue , 2014, Pages 51-58

  Mather, Stuart T ^a   Wright, Edward ^b   Scott, Simon D ^a   Temperton, Nigel J ^a  

^a UNIVERSITY OF KENT   (United Kingdom)

^b UNIVERSITY OF WESTMINSTER   (United Kingdom)

Author keywords

Lyophilisation; Neutralising antibodies; Retroviral pseudotype viruses; Serological assays

Indexed keywords

VIRUS GLYCOPROTEIN; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ANIMAL CELL; ARTICLE; BIOSAFETY; CONTROLLED STUDY; DIAGNOSTIC KIT; DOSE TIME EFFECT RELATION; EMBRYO; FREEZE DRYING; HUMAN; HUMAN CELL; HUMIDITY; INFLUENZA VIRUS A H5N1; MARBURG VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN STRUCTURE; PSEUDOTYPE VIRUS NEUTRALISATION ASSAY BASED KIT; RABIES VIRUS; RECEPTOR BINDING; SERODIAGNOSIS; TEMPERATURE SENSITIVITY; VIRUS ENTRY; VIRUS INFECTIVITY; VIRUS NEUTRALIZATION; VIRUS STRAIN; VIRUS TITRATION; VIRUS VIABILITY; ANIMAL; HEK293 CELL LINE; IMMUNOLOGY; INFLUENZA; INFLUENZA A VIRUS (H5N1); ISOLATION AND PURIFICATION; MARBURG HEMORRHAGIC FEVER; MARBURGVIRUS; RABIES; VIROLOGY;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; FREEZE DRYING; HEK293 CELLS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; MARBURG VIRUS DISEASE; MARBURGVIRUS; RABIES; RABIES VIRUS;

EID: 84908503716     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2014.09.021     Document Type: Article

References (41)

1. Assar S.K., Block S.S. Survival of microorganisms in the environment. Disinfection, Sterilization and Preservation 2001, 1221-1242. Lippincott Williams and Wilkins, Phildelphia, Pennsylvania (PA), USA. S.S. Block (Ed.).
2. Berge T.O., Jewett R.L., Blair W.O. Preservation of enteroviruses by freeze-drying. Appl. Microbiol. 1971, 22:850-853.
3. Brauburger K., Hume A.J., Mühlberger E., Olejnik J. Forty-five years of Marburg virus research. Viruses 2012, 4:1878-1927.
4. Capecchi B., Fasolo A., Alberini I., Baudner B., Crotta S., Temperton N.J., Montomoli E., Del Guidice G., Rappuoli R. Use of pseudotyped particles expressing influenza A/Vietnam/1194/2004 hemagglutinin in neutralization assays. Options for the Control of Influenza VI 2008, 303-305. International Medical Press, London. J. Katz (Ed.).
5. Cliquet F., Aubert M., Sagné L. Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody. J. Immunol. Methods 1998, 212:79-87.
6. Cox R.J., Mykkeltvedt E., Robertson J., Haaheim L.R. Non-lethal viral challenge of influenza haemagglutinin and nucleoprotein DNA vaccinated mice results in reduced viral replication. Scand. J. Immunol. 2002, 55:14-23.
7. Croyle M.A., Cheng X., Wilson J.M. Development of formulations that enhance physical stability of viral vectors for gene therapy. Gene Ther. 2001, 8:1281-1290.
8. Demaison C., Parsley K., Brouns G., Scherr M., Battmer K., Kinnon C., Grez M., Thrasher A.J. High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. Hum. Gene Ther. 2002, 13:803-813.
9. Desvaux S., Garcia J.M., Nguyen T.D., Reid S.A., Bui N.A., Roger F., Fenwick S., Peiris J.S.M., Ellis T. Evaluation of serological tests for H5N1 avian influenza on field samples from domestic poultry populations in Vietnam: consequences for surveillance. Vet. Microbiol. 2012, 156:277-284.
10. Fellowes O.N. Freeze-drying of foot-and-mouth disease virus and storage stability of the infectivity of dried virus at 4°C. Appl. Microbiol. 1965, 13:496-499.
11. Gao R., Cao B., Hu Y., Feng Z., Wang D., Hu W., Chen J., Jie Z., Qiu H., Xu K., Xu X., Lu H., Zhu W., Gao Z., Xiang N., Shen Y., He Z., Gu Y., Zhang Z., Yang Y., Zhao X., Zhou L., Li X., Zou S., Zhang Y., Li X., Yang L., Guo J., Dong J., Li Q., Dong L., Zhu Y., Bai T., Wang S., Hao P., Yang W., Zhang Y., Han J., Yu H., Li D., Gao G.F., Wu G., Wang Y., Yuan Z., Shu Y. Human infection with a novel avian-origin influenza A (H7N9) virus. N. Engl. J. Med. 2013, 368:1888-1897.
12. Higashikawa F., Chang L. Kinetic analyses of stability of simple and complex retroviral vectors. Virology 2001, 280:124-131.
13. Jackson A.C. Current and future approaches to the therapy of human rabies. Antiviral Res. 2013, 99:61-67.
14. Kaku Y., Noguchi A., Marsh G.A., Barr J.A., Okutani A., Hotta K., Bazartseren B., Fukushi S., Broder C.C., Yamada A., Inoue S., Wang L.-F. Second generation of pseudotype-based serum neutralization assay for Nipah virus antibodies: sensitive and high-throughput analysis utilizing secreted alkaline phosphatase. J. Virol. Methods 2012, 179:226-232.
15. Kishishita N., Takeda N., Anuegoonpipat A., Anantapreecha S. Development of a pseudotyped-lentiviral-vector-based neutralization assay for chikungunya virus infection. J. Clin. Microbiol. 2013, 51:1389-1395.
16. Loi P., Matsukawa K., Ptak G., Clinton M., Fulka J., Nathan Y., Arav A. Freeze-dried somatic cells direct embryonic development after nuclear transfer. PLOS ONE 2008, 3:e2978.
17. Lowen A.C., Mubareka S., Steel J., Palese P. Influenza virus transmission is dependent on relative humidity and temperature. PLOS Pathog. 2007, 3:1470-1476.
18. Mather S., Scott S., Temperton N., Wright E., King B., Daly J. Current progress with serological assays for exotic emerging/re-emerging viruses. Future Virol. 2013, 8:745-755.
19. Molesti E., Milani A., Terregino C., Cattoli G., Temperton N.J. Comparative serological assays for the study of h5 and h7 avian influenza viruses. Influenza Res. Treat. 2013, 2013:286158. 10.1155/2013/286158.
20. Noti J.D., Blachere F.M., McMillen C.M., Lindsley W.G., Kashon M.L., Slaughter D.R., Beezhold D.H. High humidity leads to loss of infectious influenza virus from simulated coughs. PLOS ONE 2013, 8:e57485.
21. Papenburg J., Baz M., Hamelin M.-È., Rhéaume C., Carbonneau J., Ouakki M., Rouleau I., De Serres G., Boivin G. Evaluation of serological diagnostic methods for the 2009 pandemic influenza A (H1N1) virus. Clin. Vaccine Immunol. 2011, 18:520-522.
22. Pear W.S., Nolan G.P., Scott M.L., Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:8392-8396.
23. Scott E.M., Woodside W. Stability of pseudorabies virus during freeze-drying and media. Stability of Pseudorabies Virus During Freeze-Drying and Storage: Effect of Suspending Media 1976.
24. Scott S., Molesti E., Temperton N., Ferrara F., Böttcher-Friebertshäuser E., Daly J. The use of equine influenza pseudotypes for serological screening. J. Mol. Genet. Med. 2012, 6:304-308.
25. Shin S., Salvay D., Shea L. Lentivirus delivery by adsorption to tissue engineering scaffolds. J. Biomed. Mater. 2010, 93:1252-1259.
26. Stoker M., MacPherson I. Syrian hamster fibroblast cell line BHK21 and its derivatives. Nature 1964, 203:1355-1357.
27. Temperton N.J., Hoschler K., Major D., Nicolson C., Manvell R., Hien V.M., Ha D.Q., de Jong M., Zambon M., Takeuchi Y., Weiss R.A. A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies. Influenza Other Respir. Viruses 2007, 1:105-112.
28. Temperton N.J., Wright E. Retroviral pseudotypes. Encyclopedia of Life Sciences 2009, John Wiley & Sons, Chichester.
29. Terregino C., Toffan A., Cilloni F., Monne I., Bertoli E., Castellanos L., Amarin N., Mancin M., Capua I. Evaluation of the protection induced by avian influenza vaccines containing a 1994 Mexican H5N2 LPAI seed strain against a 2008 Egyptian H5N1 HPAI virus belonging to clade 2.2.1 by means of serological and in vivo tests. Avian Pathol. 2010, 39:215-222.
30. To K.K.W., Tsang A.K.L., Chan J.F.W., Cheng V.C.C., Chen H., Yuen K.-Y. Emergence in China of human disease due to avian influenza A(H10N8) - cause for concern?. J. Infect. 2014, 68:205-215.
31. Tong S., Zhu X., Li Y., Shi M., Zhang J., Bourgeois M., Yang H., Chen X., Recuenco S., Gomez J., Chen L.-M., Johnson A., Tao Y., Dreyfus C., Yu W., McBride R., Carney P.J., Gilbert A.T., Chang J., Guo Z., Davis C.T., Paulson J.C., Stevens J., Rupprecht C.E., Holmes E.C., Wilson I.A., Donis R.O. New world bats harbor diverse influenza A viruses. PLOS Pathog. 2013, 9:e1003657. 10.1371/journal.ppat.1003657.
32. Tyrrell D.A., Ridgwell B. Freeze-drying of certain viruses. Nature 1965, 206:115-116.
33. Wei S.-H., Yang J.-R., Wu H.-S., Chang M.-C., Lin J.-S., Lin C.-Y., Liu Y.-L., Lo Y.-C., Yang C.-H., Chuang J.-H., Lin M.-C., Chung W.-C., Liao C.-H., Lee M.-S., Huang W.-T., Chen P.-J., Liu M.-T., Chang F.-Y. Human infection with avian influenza A H6N1 virus: an epidemiological analysis. Lancet Respir. Med. 2013, 1:771-778.
34. WHO Pandemic (H1N1) 2009 Update 112. Global Alert and Response, Geneva 2010.
35. WHO Rabies Fact Sheet No. 99, Geneva 2013.
36. Wilschut J., de Jonge J., Huckriede A., Amorij J.-P., Hinrichs W.L.J., Frijlink H.W. Preservation of influenza virosome structure and function during freeze-drying and storage. J. Liposome Res. 2007, 17:173-182.
37. Wright E., Hayman D.T.S., Vaughan A., Temperton N.J., Wood J.L.N., Cunningham A.A., Suu-Ire R., Weiss R.A., Fooks A.R. Virus neutralising activity of African fruit bat (Eidolon helvum) sera against emerging lyssaviruses. Virology 2010, 408:183-189.
38. Wright E., McNabb S., Goddard T., Horton D.L., Lembo T., Nel L.H., Weiss R.A., Cleaveland S., Fooks A.R. A robust lentiviral pseudotype neutralisation assay for in-field serosurveillance of rabies and lyssaviruses in Africa. Vaccine 2009, 27:7178-7186.
39. Wright E., Temperton N.J., Marston D.A., McElhinney L.M., Fooks A.R., Weiss R.A. Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross-species comparison. J. Gen. Virol. 2008, 89:2204-2213.
40. Yuen K.Y., Chan P.K., Peiris M., Tsang D.N., Que T.L., Shortridge K.F., Cheung P.T., To W.K., Ho E.T., Sung R., Cheng A.F. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998, 351:467-471.
41. Zufferey R., Nagy D., Mandel R.J., Naldini L., Trono D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 1997, 15:871-875.